Updates

CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS

Apr 3, 2024

President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press Read More

Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable

Mar 22, 2024

CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings Read More

THEN VS. NOW: PFIZER LATEST BIG PHARMA GIANT TO ACCIDENTALLY DEBUNK INDUSTRY’S OWN DOOM-AND-GLOOM INNOVATION RHETORIC

Mar 7, 2024

Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO Read More

BIG PHARMA WATCH: BIG PHARMA SET NEW RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2023, UP 35 PERCENT FROM PREVIOUS YEAR

Feb 26, 2024

Median Price Set by Brand Name Drug Makers on New Treatments Climbs to Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK

Feb 22, 2024

GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023, Read More

BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE

Feb 15, 2024

More Big Pharma Giants Report Earnings That Top Wall Street Expectations While Read More

DOSE OF REALITY: BIG PHARMA CEOS FACE A RECKONING FROM LAWMAKERS AND EXPERTS ON ANTI-COMPETITIVE PRACTICES AND PRICE GOUGING

Feb 12, 2024

Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices Read More

BIG PHARMA EARNINGS WATCH: PFIZER & GLAXOSMITHKLINE

Feb 9, 2024

Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer Read More

Advisory: Panel Discussion on Big Pharma’s Patent Abuse with CSRxP Executive Director Lauren Aronson

Feb 6, 2024

Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jan 31, 2024

Big Pharma Giant Kicks Off Q4 Earnings After Hiking Prices More Than 40 Times Read More

DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS DRIVE HIGHER HEALTH CARE COSTS

Jan 30, 2024

Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive Read More